NEW YORK, March 4, 2015 (GLOBE NEWSWIRE) — The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who purchased Medbox, Inc. (“Medbox” or the “Company”) (OTC MKTS:MDBX) securities between November 20, 2013 and December 29, 2014.
Click here to learn about the case:https://docs.wongesq.com/MDBX-Info-Request-Form-623. There is no cost or obligation to you.
The complaint alleges that during the Class Period defendants concealed that: (a) Medbox was recognizing revenue before earned on certain customer contracts; (b) the Company lacked effective internal controls; (c) due to its false financial reporting, Medbox was not complying with Generally Accepted Accounting Principles or SEC rules and regulations, and thus was not eligible for listing on the national exchange; (d) due to its financial misstatements, Medbox was not in compliance with its debt covenants; and (e) as a result of the aforementioned, Medbox was not on track to achieve its financial targets during the Class Period.
If you suffered a loss in Medbox you have until March 23, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.425.1140, or visit https://docs.wongesq.com/MDBX-Info-Request-Form-623.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: vw@wongesq.com
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
